Clinical Criteria for the Assessment of Permanent Cerebrospinal fluid Shunting after Endovascularly Treated Aneurysmal Subarachnoid Hemorrhage: The “Endovascular Treatment and Risk of Shunt” Score
Journal of Neurological Surgery Part A: Central European Neurosurgery · 2026-08-01 · 87 (05) · 319-328
DOI: 10.1055/a-2848-6936 ↗Abstract
Abstract Objective An exact classification for estimating the risk of shunt-dependent hydrocephalus (SDHC) after endovascularly treated aneurysmal subarachnoid hemorrhage (aSAH) is still missing, although studies underline that the type of aneurysm care (clipping/coiling) has a decisive influence on the development of an SDHC. Methods A total of 91 patients who underwent an endovascularly treated aSAH at the Department of Neurosurgery of the University Hospital Augsburg from January 2010 to July 2015 were selected. Clinical variables, radiographic features, and amount of cerebrospinal fluid (CSF) drainage via external ventricular drainage (EVD) were included in the scoring process. We determined the optimal cutoff values by an univariate logistic regression for each dichotomized variable and the Akaike Information Criterion (AIC). Finally, the “Endovascular Treatment and Risk of Shunt” (EROS) score was established. Results A ventricular score >0.6 (p < 0.001), poor Glasgow Coma Scale (GCS) score (3 points showed a significantly high risk of shunt dependency. Conclusion The EROS score is easy to determine and showed a good predictive value in the investigated patient population. Prospective validation is still needed.
EUVIMED